文献速递眼底病与葡萄膜炎

穆勒胶质细胞自诱导TGF-β通过胶质-间充质转化促进糖尿病纤维血管增生

Involvement of Müller Glial Autoinduction of TGF-β in Diabetic Fibrovascular Proliferation Via Glial-Mesenchymal Transition.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

本研究探讨穆勒胶质细胞胶质-间充质转化(GMT)在增殖性糖尿病视网膜病变纤维血管增生中的作用。发现患者纤维血管组织中穆勒细胞表达GMT标志物并共定位VEGF-A与TGF-β受体;体外TGF-β1/2可自诱导TGFB1/TGFB2并诱导VEGFA表达,涉及NF-κB、GSK-3、p38 MAPK和PI3K/SMAD2信号。结论提示穆勒胶质细胞自诱导TGF-β是驱动GMT和VEGF-A依赖血管生成的关键致病线索。

要点

  • 患者纤维血管组织中穆勒细胞表达SNAIL、SM22等GMT标志物并共定位VEGF-A与TGF-β受体
  • TGF-β1/2可自诱导穆勒细胞TGFB1/TGFB2,该过程受NF-κB、GSK-3和p38 MAPK抑制
  • TGF-β1/2通过p38 MAPK、PI3K和SMAD2通路诱导穆勒细胞VEGFA表达

核心结论

  • 穆勒胶质细胞自诱导TGF-β是促进糖尿病纤维血管增生的重要致病线索,通过TGF-β驱动的GMT和VEGF-A驱动的血管生成实现。

研究设计与样本

  • 对增殖性糖尿病视网膜病变患者手术切除的纤维血管组织进行免疫荧光分析TGF-β下游分子。
  • 使用人穆勒胶质细胞,通过实时定量PCR和ELISA评估基因和蛋白表达变化,免疫印迹检测TGF-β信号激活。

主要发现

  • 患者纤维血管组织中穆勒胶质细胞免疫阳性表达GMT相关标志物SNAIL和平滑肌蛋白22(SM22),并共定位VEGF-A与TGF-β受体。
  • 体外TGF-β1/2上调TGFB1和TGFB2,该上调被NF-κB、GSK-3和p38 MAPK抑制剂抑制。
  • TGF-β1/2选择性诱导穆勒细胞VEGFA mRNA表达,该诱导被SMAD2 siRNA及p38 MAPK和PI3K抑制剂减弱。
  • TGF-β1/2刺激增加穆勒细胞中p38 MAPK、PI3K和SMAD2的磷酸化,这些信号分子在患者纤维血管组织穆勒细胞中也被激活。

临床怎么用

  • 提示靶向穆勒胶质细胞TGF-β自诱导及其下游p38 MAPK、PI3K和SMAD2信号可能干预糖尿病纤维血管增生。
  • TGF-β驱动的GMT和VEGF-A产生是潜在治疗靶点,但需进一步临床验证。

局限性

  • 研究主要基于体外细胞实验和患者组织免疫荧光分析,样本量未报告,需进一步体内和临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Müller glial-mesenchymal transition (GMT) is reported as the fibrogenic mechanism promoted by TGF-β-SNAIL axis in Müller cells transdifferentiated into myofibroblasts. Here we show the multifaceted involvement of TGF-β in diabetic fibrovascular proliferation via Müller GMT and VEGF-A production. METHODS: Surgically excised fibrovascular tissues from the eyes of patients with proliferative diabetic retinopathy were processed for immunofluorescence analyses of TGF-β downstream molecules. Human Müller glial cells were used to evaluate changes in gene and protein expression with real-time quantitative PCR and ELISA, respectively. Immunoblot analyses were performed to detect TGF-β signal activation. RESULTS: Müller glial cells in patient fibrovascular tissues were immunopositive for GMT-related molecular markers, including SNAIL and smooth muscle protein 22, together with colocalization of VEGF-A and TGF-β receptors. In vitro administration of TGF-β1/2 upregulated TGFB1 and TGFB2, both of which were suppressed by inhibitors for nuclear factor-κB, glycogen synthase kinase-3, and p38 mitogen-activated protein kinase. Of the various profibrotic cytokines, TGF-β1/2 application exclusively induced Müller glial VEGFA mRNA expression, which was decreased by pretreatment with small interfering RNA for SMAD2 and inhibitors for p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Supporting these findings, TGF-β1/2 stimulation to Müller cells increased the phosphorylation of these intracellular signaling molecules, all of which were also activated in Müller glial cells in patient fibrovascular tissues. CONCLUSIONS: This study underscored the significance of Müller glial autoinduction of TGF-β as a pathogenic cue to facilitate diabetic fibrovascular proliferation via TGF-β-driven GMT and VEGF-A-driven angiogenesis.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wu D, Kanda A, Liu Y, et al. Involvement of Müller Glial Autoinduction of TGF-β in Diabetic Fibrovascular Proliferation Via Glial-Mesenchymal Transition. Invest Ophthalmol Vis Sci. 2020. PMID: 33369638. doi:10.1167/iovs.61.14.29

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。